Ever Supreme Bio Technology Co has a quick ratio of 1.60. It generally indicates good short-term financial strength.
The historical rank and industry rank for Ever Supreme Bio Technology Co's Quick Ratio or its related term are showing as below:
ROCO:6712'
s Quick Ratio Range Over the Past 10 Years
Min: 1.6 Med: 12.8 Max: 292.41
Current: 1.6
During the past 10 years, Ever Supreme Bio Technology Co's highest Quick Ratio was 292.41. The lowest was 1.60. And the median was 12.80.
ROCO:6712's Quick Ratio is ranked worse than 70.99% of 1410
companies
in the Biotechnology industry
Industry Median: 3.6
vs ROCO:6712: 1.60
Ever Supreme Bio Technology Co (ROCO:6712) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Ever Supreme Bio Technology Co Quick Ratio Related Terms
Ever Supreme Bio Technology Co Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6712 vs VRTX, REGN, ALNY: Quick Ratio Comparison
For the Biotechnology subindustry, Ever Supreme Bio Technology Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ever Supreme Bio Technology Co Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ever Supreme Bio Technology Co's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Ever Supreme Bio Technology Co's Quick Ratio falls into.
Ever Supreme Bio Technology Co Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ever Supreme Bio Technology Co (ROCO:6712) has a Quick Ratio of 1.60 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Ever Supreme Bio Technology Co and its competitors. This is 88% below median its historical median of 12.80. Over the past decade, Ever Supreme Bio Technology Co's Quick Ratio has ranged from 1.60 to 292.41. According to the industry distribution chart, Ever Supreme Bio Technology Co ranks #1001 out of 1410 companies in the Biotechnology industry, placing it in the top 71%.
Is Ever Supreme Bio Technology Co's Quick Ratio too high?
Ever Supreme Bio Technology Co's current Quick Ratio of 1.60 is 88% below median its 10-year median of 12.80. Over the past 10 years, this metric has ranged from a low of 1.60 to a high of 292.41. The Biotechnology industry median Quick Ratio is 3.60. Ever Supreme Bio Technology Co's value of 1.60 is 55.6% below this industry median. Based on the distribution chart, Ever Supreme Bio Technology Co ranks #1001 out of 1410 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Ever Supreme Bio Technology Co has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ever Supreme Bio Technology Co's Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Ever Supreme Bio Technology Co ranks #1001 out of 1410 companies for Quick Ratio. This places Ever Supreme Bio Technology Co in the lower half of its industry. The industry median Quick Ratio is 3.60. Ever Supreme Bio Technology Co's value of 1.60 is 55.6% below this benchmark. Historically, Ever Supreme Bio Technology Co's own Quick Ratio has ranged from 1.60 to 292.41 over the past decade. While the company's 10-year median is 12.80 vs. the industry median of 3.60, Ever Supreme Bio Technology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.60, based on 1,410 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ever Supreme Bio Technology Co's current Quick Ratio of 1.60 is 55.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Ever Supreme Bio Technology Co and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ever Supreme Bio Technology Co's current Quick Ratio is 1.60, which is 88% below median its own 10-year median of 12.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ever Supreme Bio Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Ever Supreme Bio Technology Co (ROCO:6712) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$211.95, compared to a current price of NT$159.50 — trading 24.7% below its estimated fair value. The current Quick Ratio is 1.60, which is 88% below median its 10-year median of 12.80 and 55.6% below the Biotechnology industry median of 3.60. Ever Supreme Bio Technology Co's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Ever Supreme Bio Technology Co (ROCO:6712), the current Quick Ratio is 1.60 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ever Supreme Bio Technology Co (ROCO:6712) Overvalued in 2026?
Based on GuruFocus' analysis, Ever Supreme Bio Technology Co stock appears to be undervalued.
The current stock price of NT$159.50 is trading 24.7% below its estimated GF Value™ of NT$211.95.
GuruFocus considers Ever Supreme Bio Technology Co to be Modestly Undervalued.
Key valuation signals for ROCO:6712:
Quick Ratio: 1.60 (88% below median its 10-year median of 12.80)
GF Value™: NT$211.95 vs. price of NT$159.50 (24.7% below fair value)
Industry Position: 55.6% below the Biotechnology median (#1001 of 1410)
No single metric tells the full story. See the ROCO:6712 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ever Supreme Bio Technology Co Business Description
Ever Supreme Bio Technology Co Ltd is a Taiwan-based company. The company is engaged in research, development, and manufacturing of new drugs related to human mesenchymal stem cells and immune cells. The company operates in two segments: Cell Preparation Business Unit and Other Operating Business. The company gained a majority of revenue from the Cell Preparation Business, which is engaged in the research, development, manufacture, and sales of various new drugs and cell preparations, and investments related to biotechnology and medical industry businesses.
88GF Score
Get the complete analysis for ROCO:6712
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6712 has been successfully added to your 
